Erratum
for
Barlogie et al., J Clin Oncol 24 (6) 929-936.
Journal of Clinical Oncology, Vol 24, No 17 (June 10), 2006: pp. 2687-a
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.04.004
ERRATUM
The February 20, 2006, article by Barlogie et al, entitled "Standard Chemotherapy Compared With High-Dose Chemotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321" (J Clin Oncol 24:929-936, 2006) contained an error. Dennis F. Moore Jr (Wichita Community Clinical Oncology Program, Wichita, KS) was inadvertently omitted from the byline. In the Author Contributions section, Dr Moore should have been acknowledged for "Final approval of the manuscript." There is no change to the Authors’ Disclosures of Potential Conflicts of Interest section. The corrected byline is reprinted below in its entirety:
Bart Barlogie, Robert A. Kyle, Kenneth C. Anderson, Philip R. Greipp, Hillard M. Lazarus, David D. Hurd, Jason McCoy, Dennis F. Moore Jr, Shaker R. Dakhil, Keith S. Lanier, Robert A. Chapman, Jeana N. Cromer, Sydney E. Salmon, Brian Durie, and John C. Crowley
The online version has been corrected in departure from the print.
|
